EARS is trying again in tinnitus: https://www.globenewswire.com/news-release/2019/09/13/1915411/0/en/Auris-Medical-Receives-FDA-and-EMA-Guidance-for-Keyzilen-Late-Stage-Clinical-Development-Program.html Why do they expect a different (i.e. successful) outcome?